WST
West Pharmaceutical Services, Inc. · NYSE
- Sector Health Technology
- Industry Medical Specialties
- Website estpharma.com
- Employees(FY) 10700
- ISIN US9553061055
Performance
-0.07%
1W
+8.98%
1M
+6.56%
3M
+3.03%
6M
-5.67%
YTD
-4.96%
1Y
Profile
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Technical Analysis of WST 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-20 08:02
- 2024-12-18 10:33
- 2024-12-17 19:00
WST: Rating decreased to a SELL(Argus Research)
- 2024-12-14 06:45
- 2024-12-13 16:25
- 2024-12-13 07:16
- 2024-12-12 19:00
West Pharmaceutical upgraded to Buy from Neutral at UBS(Yahoo Finance)
- 2024-12-12 10:02
- 2024-12-11 06:00
West Elects New Director to the Board(PR Newswire)
- 2024-12-10 19:00
WST: Lowering target price to $335.00(Argus Research)
- 2024-12-10 17:00
West Elects New Director to the Board(Prnewswire)
- 2024-12-10 09:31
- 2024-12-03 19:00
WST: Raising target price to $338.00(Argus Research)
- 2024-11-29 11:40
- 2024-11-27 09:04
- 2024-11-26 19:00
WST: Rating increased to a HOLD(Argus Research)
- 2024-11-19 08:24
- 2024-11-17 20:09
- 2024-11-16 10:12
- 2024-11-12 19:00
WST: Raising target price to $282.00(Argus Research)
- 2024-11-05 19:00
WST: Raising target price to $280.00(Argus Research)
- 2024-10-30 12:15
- 2024-10-29 06:00
West to Participate in Upcoming Investor Conferences(PR Newswire)
- 2024-10-29 04:34
- 2024-10-28 18:00
- 2024-10-28 14:00
- 2024-10-26 01:03
- 2024-10-25 12:16
- 2024-10-25 11:10
- 2024-10-25 09:16
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.